CAS NO: | 1361951-15-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | TP-3654 is a second-generationPimkinase inhibitor withKivalues of 5 and 42 nM for Pim-1 and Pim-3, respectively. | ||||||||||||||||
IC50& Target | Ki: 5 nm(Pim-1), 239 nM (Pim-2), 42 nM (Pim-3)[1] | ||||||||||||||||
体外研究 (In Vitro) | TP-3654 demonstrates potent PIM-1 specific cellular activity in the PIM-1/BAD overexpression system with an average EC50of 67 nM. TP-3654 treatment reduces levels of phospho-BADin vitrousing the bladder cancer cell line UM-UC-3. TP-3654 reduces colony growth of T24 and UM-UC3 cells, confirming the PIM-1–dependent growth for both cell lines[1]. | ||||||||||||||||
体内研究 (In Vivo) | Oral dosing of 200 mg/kg TP-3654 significantly reduces both UM-UC-3 and PC-3 tumor growth measured by volume (caliper) and by final tumor weight, with no significant changes in body weight or gross adverse toxicity[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 418.46 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C22H25F3N4O | ||||||||||||||||
CAS 号 | 1361951-15-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(119.49 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|